Si­en­na Bio bags $65M in the lat­est suc­cess­ful biotech IPO

Bustling along with a pipeline of ther­a­pies for var­i­ous skin con­di­tions, Si­en­na Bio­phar­ma­ceu­ti­cals has raised about $65 mil­lion from its IPO af­ter pric­ing 4 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.